US Patent Issued to CHONG KUN DANG PHARMACEUTICAL on Jan. 13 for "1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,601, issued on Jan. 13, was assigned to CHONG KUN DANG PHARMACEUTICAL CORP. (Seoul, South Korea).

"1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same" was invented by Chang Kon Lee (Yongin-si, South Korea), Moo Sung Ko (Yongin-si, South Korea), Seok Hyoun Yun (Yongin-si, South Korea), Seo Young Lee (Yongin-si, South Korea) and Hyunjin Michael Kim (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel compound having a histone deacetylase 6 (HDAC6) inhibitory activity, an isomer thereof or a pharmaceutically acceptabl...